These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33976639)

  • 1. Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases.
    Mroczkowska A; Lejman M
    Case Rep Oncol; 2021; 14(1):592-598. PubMed ID: 33976639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
    Tsuchiya KD; Davis B; Gardner RA
    Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population.
    Fuka G; Farias-Vieira TM; Hummel L; Blunck CB; Santoro JC; Terra-Granado E; Barbosa TC; Emerenciano M; Pombo-de-Oliveira MS
    Mol Cytogenet; 2015; 8():35. PubMed ID: 26060508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrachromosomal amplification of chromosome 21 (iAMP21) detected by ETV6/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case report.
    Garcia DR; Arancibia AM; Ribeiro RC; Land MG; Silva ML
    Rev Bras Hematol Hemoter; 2013; 35(5):369-71. PubMed ID: 24255623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution.
    Yang M; Yi ES; Kim HJ; Yoo KH; Koo HH; Kim SH
    Blood Res; 2017 Jun; 52(2):100-105. PubMed ID: 28698845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia.
    Duployez N; Boudry-Labis E; Decool G; Grzych G; Grardel N; Abou Chahla W; Preudhomme C; Roche-Lestienne C
    Clin Case Rep; 2015 Oct; 3(10):814-6. PubMed ID: 26509013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful hematopoietic stem cell transplantation for two patients with relapse of intrachromosomal amplification of chromosome 21-positive B-cell precursor acute lymphoblastic leukemia.
    Harada T; Toyoda H; Tsuboya N; Hanaki R; Amano K; Hirayama M
    Front Pediatr; 2022; 10():960126. PubMed ID: 36160794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
    Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
    Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
    Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
    Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
    Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
    Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
    Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB
    Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.
    Harrison CJ; Moorman AV; Schwab C; Carroll AJ; Raetz EA; Devidas M; Strehl S; Nebral K; Harbott J; Teigler-Schlegel A; Zimmerman M; Dastuge N; Baruchel A; Soulier J; Auclerc MF; Attarbaschi A; Mann G; Stark B; Cazzaniga G; Chilton L; Vandenberghe P; Forestier E; Haltrich I; Raimondi SC; Parihar M; Bourquin JP; Tchinda J; Haferlach C; Vora A; Hunger SP; Heerema NA; Haas OA;
    Leukemia; 2014 May; 28(5):1015-21. PubMed ID: 24166298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
    Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
    J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
    Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
    Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Zachariadis V; Taylan F; Marincevic-Zuniga Y; Tran AN; Saft L; Nilsson D; Syvänen AC; Lönnerholm G; Harila-Saari A; Nordenskjöld M; Heyman M; Nordgren A; Nordlund J; Barbany G
    Leuk Lymphoma; 2020 Mar; 61(3):604-613. PubMed ID: 31640433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of iAMP21 and
    Gu J; Reynolds A; Fang L; DeGraffenreid C; Sterns K; Patel KP; Medeiros LJ; Lin P; Lu X
    Mol Cytogenet; 2016; 9():84. PubMed ID: 27895713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
    Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ
    J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
    Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
    Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
    Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.